All News & Stories
Family history remains on the National Cancer Institute’s list of risk factors for breast cancer, but what does it mean when cancer “runs in the family?"
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.
This Press Ganey award recognizes institutions who have maintained consistently high levels of excellence in patient experience over a three-year period.
Five Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer.
A newly awarded $820,000 grant from The National Cancer Institute (NCI) will allow a team of investigators to increase clinical trial awareness and participation for rural patients.
NCCC researchers achieve conversion of a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver a ‘FLASH’ ultra-high dose rate radiation therapy beam in standard patient geometry.
Sarcomas develop in bones or connective tissues. Here are 10 things you may not know about this uncommon group of cancers.
Four years after completing treatment for colon cancer, Dia Draper reflects on life in survivorship and the complex emotions and changes in life perspective that come along with surviving a serious illness.